Tamsulosin
Tamsulosin is an **alpha-1 adrenergic antagonist** with high selectivity for the urinary tract. It works by relaxing the smooth muscle in the prostate, urethra, and bladder neck, thereby aiding urine flow. It has a longer duration of action compared to other alpha-blockers like prazosin or phenoxybenzamine. **Clinical Pearl:** In veterinary medicine, tamsulosin is frequently used off-label to manage functional urinary retention, benign prostatic hyperplasia (BPH) in intact male dogs, and to facilitate the medical expulsive therapy of ureteroliths or uroliths.
Mechanism: Tamsulosin selectively binds to and blocks **alpha-1A and alpha-1D adrenergic receptors** located predominantly in the smooth muscle of the prostate, prostatic capsule, prostatic urethra, and bladder neck. Blockade of these receptors → relaxation of smooth muscle → decreased urethral resistance → improved urine flow and relief of functional urinary obstruction.
Routes of administration
Contraindications
- Hypersensitivity to tamsulosin
- Severe hepatic impairment
- History of orthostatic hypotension
Adverse effects
- Hypotension
- Lethargy
- Weakness
- Gastrointestinal upset (vomiting, diarrhea)
- Dizziness
Drug interactions
- Other alpha-1 blockers (e.g., prazosin, phenoxybenzamine) · Additive hypotensive effects · major
- Calcium channel blockers (e.g., amlodipine) · Increased risk of hypotension · moderate
- Cimetidine · Decreased clearance of tamsulosin, potentially increasing plasma concentrations · minor
Monitoring
- Urine output and ease of urination
- Blood pressure
- Renal function
Overdose
Overdosage may lead to severe **hypotension**. Treatment is primarily supportive, including intravenous fluid therapy and potentially vasopressors if hypotension is refractory. Emesis or gastric lavage may be considered if ingestion is recent.
VetSheet drug reference is intended for licensed veterinary professionals as a clinical decision-support aid, not a substitute for professional judgement or the manufacturer’s current label.